Journal of Clinical and Cellular Immunology
Open Access
ISSN: 2155-9899
ISSN: 2155-9899
Jagat R. Kanwar
Jagat Kanwar
Associate Professor
Department of Immunology & Cell Biology
Deakin University
Australia
Dr. Jagat Kanwar is an Associate Professor of Immunology & Cell Biology, and Group Leader in “Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research” at Deakin University, Australia. He did his PhD in 1993 from PGIMER, Chandigarh, India. He worked as a Senior Scientist in The Auckland University, New Zealand for more than 10 years. Dr. Jagat Kanwar has a national and international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. His research is also focused on miRNA, aptamer, locked nucleic acid (LNA) LNA-modified chimeric aptamers-siRNA conjugates, and immunoliposomes technology and disease targeted drug discovery. His research combines Immunology with state of the art and cutting edge techniques in Molecular Biology, Biochemistry, Nanobiotechnology and visualization to investigate the pathways in which key molecules are regulated in both normal and disease states. Dr. Jagat Kanwar designed nanocarriers for applications in vaccines, immunotherapy, and drug delivery of antigens immunostimulatory ligands to dendritic cells and subsequent stimuli to T- lymphocytes, B-lymphocytes and TH17 cells. Dr. Jagat Kanwar research interests include Cancer and chronic inflammatory diseases targeted nanomedicine based drug delivery. siRNA, miRNA anti-sense targeted gene nanomedicine based technology to target cancer and inflammation, Drug discovery with anticancer targets for cancer cell survival, death, arrest, and repair.
Cancer and chronic inflammatory diseases targeted nanomedicine based drug delivery. siRNA, miRNA anti-sense targeted gene nanomedicine based technology to target cancer and inflammation, Drug discovery with anticancer targets for cancer cell survival, death, arrest, and repair.